Galvin Gaustad & Stein’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28M Sell
59,229
-8,142
-12% -$4.1M 2.24% 4
2025
Q4
$31.5M Sell
67,371
-16,874
-20% -$7.83M 2.45% 5
2025
Q3
$35.9M Buy
84,245
+324
+0.4% +$126K 2.92% 2
2025
Q2
$32.1M Buy
83,921
+5,814
+7% +$2.1M 2.77% 4
2025
Q1
$27M Buy
78,107
+17,992
+30% +$5.79M 2.41% 8
2024
Q4
$18M Buy
+60,115
New +$21M 1.62% 21

Other funds holding HCA

Galvin Gaustad & Stein's HCA Position: Q1 2026 in Review

Galvin Gaustad & Stein reduced its HCA Healthcare (HCA) stake by 12% in Q1 2026, selling an estimated $4.1M and leaving 59,229 shares worth $28M. The position accounts for 2.24% of the portfolio, ranked #4.

Galvin Gaustad & Stein first reported a position in HCA in Q4 2024 and has held it in 6 quarters since. The position peaked at $35.9M in Q3 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Galvin Gaustad & Stein held 59,229 shares of HCA Healthcare worth $28M as of Q1 2026.
  • Galvin Gaustad & Stein sold 8,142 HCA Healthcare shares in Q1 2026, an estimated $4.1M.
  • HCA Healthcare made up 2.24% of Galvin Gaustad & Stein's portfolio in Q1 2026, its #4 holding.
  • Galvin Gaustad & Stein first reported a position in HCA Healthcare in Q4 2024 and has held it in 6 quarters since.
  • Galvin Gaustad & Stein's HCA Healthcare position peaked at $35.9M in Q3 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q1 2026, filed 14 May 2026.